Trade Vir Biotechnology VIR

Sell
 Buy

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 Jun 04, 00:39

Insider Selling: Vir Biotechnology, Inc. (NASDAQ:VIR) Director Sells 3,200 Shares of Stock

Vir Biotechnology Inc
Webhose 2025 Jun 03, 07:38

Nuveen Asset Management LLC Has $2.64 Million Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Jun 02, 00:00

Vir Biotechnology Inc. (VIR) - Insider Monkey

Vir Biotechnology Inc
Webhose 2025 May 31, 16:48

Vir Biotechnology (NASDAQ:VIR) Stock Price Down 7.6% - Here's What Happened

Vir Biotechnology Inc
Webhose 2025 May 30, 18:08

Vir Biotechnology (NASDAQ:VIR) Trading 6.6% Higher - What's Next?

Vir Biotechnology Inc
Webhose 2025 May 27, 00:00

Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections

Vir Biotechnology Inc
Webhose 2025 May 24, 12:10

Vir Biotechnology's (VIR) Buy Rating Reaffirmed at Needham & Company LLC

Vir Biotechnology Inc
Webhose 2025 May 22, 08:42

Point72 Asset Management L.P. Raises Stock Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 May 20, 21:26

Company Website: https://vir.bio SAN FRANCISCO -- (Busines

Vir Biotechnology Inc
Webhose 2025 May 20, 11:02

Stonepine Capital Management LLC Takes Position in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 May 15, 11:52

Orbimed Advisors LLC Reduces Stock Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 May 15, 09:25

Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Acquired by Hudson Bay Capital Management LP

Vir Biotechnology Inc

VirBiotechnology news

Latest news

Show more

Info

Spread

0.05

Spread (%)

0.9634 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

725749504

Shares Outstanding

138238000

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date 

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-4.09

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
view_all_instruments

Latest Education Articles

Show more
Trustpilot